Vaccination with the pneumococcal 7-valent conjugate: A successful experiment but the species is adapting

Expert Review of Vaccines

Volumn 6, Issue 3, 2007, Pages 297-300

  Beall, Bernard ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL DNA; BACTERIOCIN; DIPHTHERIA TOXOID; PENICILLIN BINDING PROTEIN; PENICILLIN G; PNEUMOCOCCAL 13 VALENT CONJUGATE VACCINE; PNEUMOCOCCAL 7 VALENT CONJUGATE VACCINE; PNEUMOCOCCAL 9 VALENT CONJUGATE VACCINE; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ADAPTATION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIUM ISOLATE; BINDING AFFINITY; CHILDHOOD; CLONE; COMMENSAL; DEVELOPING COUNTRY; DNA SEQUENCE; DRUG BINDING; DRUG COST; EDITORIAL; GENE LOCUS; GENE STRUCTURE; GENE SWITCHING; GENETIC RECOMBINATION; GENOTYPE; GROUPS BY AGE; HUMAN; INCIDENCE; INFLUENZA; MULTIDRUG RESISTANCE; NASOPHARYNX; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; TAIWAN; UNITED STATES; VACCINATION; VIRUS PNEUMONIA;

ADAPTATION, PHYSIOLOGICAL; GENES, BACTERIAL; HUMANS; MENINGOCOCCAL VACCINES; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RECOMBINATION, GENETIC; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 34250328728     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.6.3.297     Document Type: Editorial

References (28)

1. Whitney CG, Farley MM, Hadler J et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348, 1737-1746 (2003).
2. Kyaw, MH, Lynfield R, Schaffner W et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N. Engl. J. Med. 354, 1455-1463 (2006).
3. Millar EV, O'Brien KL, Watt JP et al. Effect of community-wide conjugate pneumococcal vaccine use in infancy on nasopharyngeal carriage through 3 years of age: a crosssectional study in a high-risk population. Clin. Infect. Dis. 43, 8-15 (2006).
4. López R. Pneumococcus: the sugar-coated bacteria. Int. Microbiol. 9, 179-190 (2006).
5. Dowson CG, Coffey TJ, Kell C, Whiley RA. Evolution of penicillin resistance in Streptococcus pneumoniae; the role of Streptococcus mitis in the formation of a low affinity PBP2B in S. pneumoniae. Mol. Microbiol. 9(3), 635-643 (1993).
6. Adrian PV, Klugman KP. Mutations in the dihydrofolate reductase gene of trimethoprim-resistant isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41(11), 2406-2413 (1997).
7. Gherardi G, Whitney CG, Facklam RR, Beall B. Major related sets of antibiotic-resistant pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbp1a-pbp2b-pbp2x-dhf restriction profiles. J. Infect. Dis. 181(1), 216-229 (2000).
8. Coffey TJ, Enright MC, Daniels M et al. Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumoniae. Mol. Microbiol. 27(1), 73-83 (1998).
9. Pai R, Moore MR, Pilishvili T et al. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J. Infect. Dis. 192, 1988-1995 (2005).
10. Brueggemann AB, Pai R, Crook DW, Beall B. Nature's experiment: vaccine escape recombinants emerge after pneumococcal vaccination. 2006. 5th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD5), Alice Springs, Australia, 2-6 April, 2006.
11. Gertz RE, Woodbury R, Gallagher G et al; for the Active Bacterial Core Surveillance Team. Clonal expansion and diversification of the major invasive pneumococcal serotype 19A in the post conjugate vaccine era. 8th European Meeting on the Molecular Biology of the Pneumococcus. Oeras, Portugal, 14-17 April, 2007.
12. Hicks LA, Harrison LH, Flannery B et al. Increase in non-vaccine-type pneumococcal disease in the era of widespread pneumococcal conjugate vaccination, United States, 1998-2004. J. Infect. Dis. (2007) (In Press).
13. Gertz RE Jr, McEllistrem MC, Boxrud DJ et al. Clonal distribution of invasive pneumococcal isolates from children and selected adults in the United States prior to 7-valent conjugate vaccine introduction. J. Clin. Microbiol. 41(9), 4194-4216 (2003).
14. Beall B, McEllistrem MC, Gertz RE Jr et al. Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002. J. Clin. Microbiol. 44(3), 999-1017 (2006).
15. Trzcinski K, Thompson CM, Lipsitch M. Single-step capsular transformation and acquisition of penicillin resistance in Streptococcus pneumoniae. J. Bacteriol. 186(11), 3447-3452 (2004).
16. Jacobs MR, Good CE, Sellner T, Bajaksouzian S, Windau A, Anon JB. Nasopharyngeal carriage of respiratory pathogens in children undergoing pressure equalization tube placement in the era of pneumococcal protein conjugate vaccine use. Laryngoscope 117(2), 295-298 (2007).
17. Hanage WP, Huang SS, Lipsitch M et al. Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the postheptavalent conjugate vaccine era. J. Infect. Dis. 195(3), 347-352 (2007).
18. McEllistrem MC, Adams JM, Patel K et al. Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin. Infect. Dis. 40(12), 1738-1744 (2005).
19. Ghaffar F, Barton T, Lozano J et al. Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life. Clin. Infect. Dis. 39, 930-938 (2004).
20. Dawid S, Roche AM, Weiser JN. The blp bacteriocins of Streptococcus pneumoniae mediate intraspecies competition both in vitro and in vivo. Infect. Immun. 75(1), 443-451 (2007).
21. Pai R, Gertz RE, Whitney CG, Beall B. Clonal association between Streptococcus pneumoniae serotype 23A, circulating within the United States, and an internationally dispersed clone of serotype 23F. J. Clin. Microbiol. 43(11), 5440-5444 (2005).
22. Beall B, McEllistrem MC, Gertz RE Jr et al; Active Bacterial Core Surveillance/Emerging Infections Program Network. Emergence of a novel penicillin-nonsusceptible, invasive serotype 35B clone of Streptococcus pneumoniae within the United States. J. Infect. Dis. 186(1), 118-122 (2002).
23. Eskola J, Kilpi T, Palmu A et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N. Engl. J. Med. 344, 403-409 (2001).
24. Ray GT. Pneumococcal conjugate vaccine: economic issues of the introduction of a new childhood vaccine. Expert Rev. Vaccines 1(1), 65-74 (2002).
25. Sniadack DH, Schwartz B, Lipman H et al. Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children - implications for vaccine strategies. Pediatr. Infect. Dis. J. 14(6), 503-510 (1995).
26. Tai ST. Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies. Crit. Rev. Microbiol. 32(3), 139-153 (2006).
27. McCullers JA, Karlstrom A, Iverson AR, Loeffler JM, Fischetti VA. Novel strategy to prevent otitis media caused by colonizing Streptococcus pneumoniae. PLoS Pathog. 3(3), e28 (2007).
28. Madhi SA, Klugman KP; Vaccine Trialist Group. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat. Med. 10(8), 811-813 (2004).